Department of Internal Medicine, Hemato-oncology, Chung-Ang University Hospital, Seoul, Korea.
J Korean Med Sci. 2009 Dec;24(6):1203-6. doi: 10.3346/jkms.2009.24.6.1203. Epub 2009 Nov 9.
This case study reports a rare fibrinogen variant, gamma Met310Thr mutation, for the first time in Korea. The case shows a point mutation from T to C in the 1,007th nucleotide of the FGG gene. This report describes a variant fibrinogen, hereinafter called "fibrinogen Yecheon", using the name after the town where the patient was living at the time of diagnosis. Fibrinogen Yecheon has a de novo heterozygous point mutation of FGG resulting in gamma Met310Thr and subsequent extra N-glycosylation at gamma Asn308. Extra N-glycosylated fibrinogen is considered a main inhibitor of normal fibrinogen activity.
本病例研究报告了一种罕见的纤维蛋白原变异体,γMet310Thr 突变,这是在韩国的首次发现。该病例显示 FGG 基因第 1007 个核苷酸处 T 到 C 的点突变。本报告描述了一种变异纤维蛋白原,以下简称“纤维蛋白原义川”,使用的名称是根据诊断时患者居住的城镇命名的。纤维蛋白原义川存在 FGG 的从头杂合性点突变,导致γMet310Thr 以及随后的γAsn308 处额外的 N-糖基化。额外的 N-糖基化纤维蛋白原被认为是正常纤维蛋白原活性的主要抑制剂。